Hoechst steps up ownership share of Dade Behring
This article was originally published in Clinica
Executive Summary
Dade Behring, which is presently one-third owned by chemicals giant Hoechst, will see that ownership increase to nearly half. The diagnostics company is to be included as part of a new life sciences division following the merger of Hoechst with Rhone-Poulenc - if the merger goes ahead.